http://orcid.org/0000-0003-4036-1030

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2024 | 2022

2024

Weber, M S R; Duran Ramirez, J J; Hentzien, M; Cavassini, M; Bernasconi, E; Hofmann, E; Furrer, H; Kovari, H; Stöckle, M; Schmid, P; Haerry, D; Braun, D L; Günthard, H F; Kusejko, K (2024). Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study. Clinical infectious diseases, 79(1), pp. 177-188. Oxford University Press 10.1093/cid/ciae014

Thoueille, Paul; Saldanha, Susana Alves; Schaller, Fabian; Choong, Eva; Veuve, François; Munting, Aline; Cavassini, Matthias; Braun, Dominique; Günthard, Huldrych F; Duran Ramirez, Jessy J; Surial, Bernard; Furrer, Hansjakob; Rauch, Andri; Ustero, Pilar; Calmy, Alexandra; Stöckle, Marcel; Di Benedetto, Caroline; Bernasconi, Enos; Schmid, Patrick; Marzolini, Catia; ... (2024). Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV. Clinical pharmacology and therapeutics, 115(6), pp. 1450-1459. Wiley 10.1002/cpt.3240

Damas, José; Munting, Aline; Fellay, Jacques; Haerry, David; Marzolini, Catia; Tarr, Philip E; Steffen, Ana; Braun, Dominique L; Stoeckle, Marcel; Bernasconi, Enos; Tshikung, Olivier Nawej; Fux, Christoph A; Darling, Katharine E A; Béguelin, Charles; Wandeler, Gilles; Cavassini, Matthias; Surial, Bernard (2024). Weight, anthropometric and metabolic changes after discontinuing antiretroviral therapy containing tenofovir alafenamide (TAF) in people with HIV. (In Press). Clinical infectious diseases Oxford University Press 10.1093/cid/ciae189

Künzler-Heule, Patrizia; Schmidt, Axel J; Fierz, Katharina; Battegay, Manuel; Engberg, Sandra; Kouyos, Roger D; Nöstlinger, Christiana; Stöckle, Marcel; Béguelin, Charles; Delaloye, Julie; Schmid, Patrick; Rougemont, Mathieu; Braun, Dominique L; Fehr, Jan S; Nicca, Dunja (2024). Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study. AIDS Care-Psychological and Socio-Medical Aspects of AIDS/HIV, 36(4), pp. 442-451. Taylor & Francis 10.1080/09540121.2023.2208318

2022

Thoueille, Paul; Alves Saldanha, Susana; Schaller, Fabian; Munting, Aline; Cavassini, Matthias; Braun, Dominique; Günthard, Huldrych F; Kusejko, Katharina; Surial, Bernard; Furrer, Hansjakob; Rauch, Andri; Ustero, Pilar; Calmy, Alexandra; Stoeckle, Marcel; Battegay, Manuel; Marzolini, Catia; Andre, Pascal; Guidi, Monia; Buclin, Thierry and Decosterd, Laurent A (2022). Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland. Pharmaceutics, 14(8) MDPI 10.3390/pharmaceutics14081588

Salazar-Vizcaya, Luisa; Kusejko, Katharina; Günthard, Huldrych F; Böni, Jürg; Metzner, Karin J; Braun, Dominique L; Nicca, Dunja; Bernasconi, Enos; Calmy, Alexandra; Darling, Katharine E A; Wandeler, Gilles; Kouyos, Roger D; Rauch, Andri (2022). An Approach to Quantifying the Interaction between Behavioral and Transmission Clusters. Viruses, 14(4) MDPI 10.3390/v14040784

Provide Feedback